Fibroblast growth factor receptors as diagnostic markers of acquired sensory neuronopathies
US10539577B2 · kind B2 · utility
0Cited by
0References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 26, 2017 |
| Grant date | Jan 21, 2020 |
| Priority date | — |
| Expiry date | Jul 26, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the diagnosis of acquired sensory neuronopathies (SNN), and to the treatment of these disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.